Gene therapy for HIV: Arizona startup Calimmune gets $15M Series B
The startup's gene therapy for HIV and AIDS spins out of the work from Nobel Laureate David Baltimore at CalTech. It's using the funding to further Phase I/II clinical trials.
calimmune